AURA

Analyst Sentiment

Wall St. Consensus
Buy
8 analysts·Limited coverage
75
Score
8 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
8100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$17.00
+119.6%
Consensus
$17.00
+119.6%
Bull
$17.00
+119.6%
12-Month Target Range8 analysts
$17.00$17.00$17.00
Current $7.74Consensus
Current Price
$7.74
Upside to Consensus
$9.26

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev-59.80%
EPS
FY2028
Rev+266.02%
EPS
FY2029
Rev+283.63%
EPS

Earnings Surprises

Recent Analyst Actions

May 12, 2026Leerink Partners
Aura Biosciences price target lowered to $17 from $26 at Leerink
Target:$17.00
+115.2%from $7.90
Mar 26, 2025JMP Securities
Aura Biosciences price target lowered to $19 from $21 at Citizens JMP
Target:$19.00
+217.2%from $5.99
Mar 25, 2025H.C. Wainwright
Aura Biosciences price target raised to $25 from $22 at H.C. Wainwright
Target:$25.00
+253.1%from $7.08
Oct 18, 2024Scotiabank
Aura Biosciences (AURA) PT Raised to $23 at Scotiabank
Target:$23.00
+123.5%from $10.29
Oct 18, 2024H.C. Wainwright
Aura Biosciences (AURA) PT Raised to $22 at H.C. Wainwright
Target:$22.00
+113.8%from $10.29
Oct 18, 2024BTIG
Aura Biosciences (AURA) PT Raised to $24 at BTIG
Target:$24.00
+133.2%from $10.29
Jul 25, 2024H.C. Wainwright
Aura Biosciences initiated with a Buy at H.C. Wainwright
Target:$21.00
+126.5%from $9.27
Nov 11, 2022JMP Securities
JMP Securities Maintains Market Outperform on Aura Biosciences, Raises Price Target to $30
Target:$30.00
+131.7%from $12.95